Coronary Stents (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

The model discusses in detail the impact of COVID-19 on Coronary Stents market for the year 2020 and beyond. US has some of the highest rates of AP and MI. However, according to secondary sources the prevalence of heart disease is decreasing. This decline may be due to preventative efforts such as lifestyle changes and reduction in smoking. In regions, such as the Middle East for example the prevalence of heart disease is increasing. The global increase in heart disease can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence. Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. The Coronary Stents Market is segmented into Bare Metal Stents, Drug Eluting Stents (DES), Covered Stents, Bioabsorbable Stents (BAS).


Who should buy this report?

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Coronary stents marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Key Highlights

Competitive Assessment

Currently marketed Coronary stents and evolving competitive landscape:

– Insightful review of the key industry trends.

– Annualized total Coronary stents market revenue by segment and market outlooks from 2015-2030.

– Granular data on total procedures, units, average selling prices and market values by segment.

Reasons to buy

The model will enable you to:

– Understand the impact of COVID-19 on Coronary stents market.

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving Coronary stents market.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary stents market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

– Track device sales in the global and country-specific Coronary stents market from 2015-2030.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies mentioned

Boston Scientific Corp

Abbott Laboratories

Medtronic plc

Biotronik AG

Lepu Medical Technology (Beijing) Co Ltd

B. Braun Melsungen AG

MicroPort Scientific Corp

Sahajanand Medical Technologies Pvt Ltd

Meril Life Sciences Pvt Ltd

Translumina Therapeutics LLP

Vascular Concepts Ltd.



Discounts available for multiple purchases.
+44 20 7947 2745

Join our mailing list

Saved reports